Medico Remedies Limited
NSE: MEDICO BSE: MEDICO
Prev Close
40.25
Open Price
43
Volume
94,144
Today Low / High
40.5 / 43
52 WK Low / High
37.18 / 62.48
Range
39 - 43
Prev Close
40.47
Open Price
40.73
Volume
919
Today Low / High
40.44 / 41.49
52 WK Low / High
35 / 63
Range
39 - 43
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 41.13 (target range: 39 - 43), reflecting a change of 0.88 (2.18634%). On the BSE, it is listed at 41.16 (target range: 39 - 43), showing a change of 0.69 (1.70497%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Medico Remedies Limited Graph
Medico Remedies Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Medico Remedies Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 41.13, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 41.16 | 41.57 | 37.41 - 45.73 |
| 41.98 | 33.59 - 50.38 | ||
| 42.39 | 29.68 - 55.11 | ||
| Bearish Scenario | 41.16 | 40.75 | 36.67 - 44.82 |
| 40.34 | 32.27 - 48.40 | ||
| 39.93 | 27.95 - 51.90 |
Overview of Medico Remedies Limited
ISIN
INE630Y01024
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
276,762
Market Cap
3,735,109,840
Last Dividend
0
Official Website
IPO Date
2022-05-26
DCF Diff
34.18
DCF
11
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 150.94 Cr | 108.33 Cr | 42.61 Cr | 0.2823 | 0.00 Cr | 4.43 Cr | 36.33 Cr | 10.09 Cr | 1.22 | 15.00 Cr | 0.0669 |
| 2024-03-31 | 144.92 Cr | 127.40 Cr | 17.52 Cr | 0.1209 | 0.00 Cr | 5.92 Cr | 10.17 Cr | 8.29 Cr | 1.00 | 17.74 Cr | 0.0572 |
| 2023-03-31 | 140.44 Cr | 104.87 Cr | 35.57 Cr | 0.2533 | 0.00 Cr | 2.72 Cr | 6.98 Cr | 7.24 Cr | 0.87 | 13.57 Cr | 0.0516 |
| 2022-03-31 | 121.02 Cr | 95.72 Cr | 17.67 Cr | 0.1460 | 0.00 Cr | 3.00 Cr | 5.22 Cr | 4.81 Cr | 0.58 | 9.33 Cr | 0.0398 |
| 2021-03-31 | 122.39 Cr | 98.98 Cr | 23.41 Cr | 0.1913 | 0.00 Cr | 2.77 Cr | 3.61 Cr | 2.59 Cr | 0.31 | 6.26 Cr | 0.0212 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.09 Cr | 119.80 Cr | 57.33 Cr | 62.4689 Cr | 14.70 Cr | 13.60 Cr | 26.73 Cr | 21.58 Cr | 0.00 Cr | 0.00 Cr | 0.20 Cr | 56.9615 Cr |
| 2024-03-31 | 0.18 Cr | 96.20 Cr | 43.82 Cr | 52.3710 Cr | 8.05 Cr | 7.87 Cr | 16.34 Cr | 21.37 Cr | 1.40 Cr | -0.14 Cr | 0.20 Cr | 42.8143 Cr |
| 2023-03-31 | 0.91 Cr | 87.45 Cr | 43.61 Cr | 43.8430 Cr | 9.76 Cr | 8.85 Cr | 19.70 Cr | 21.83 Cr | 0.43 Cr | 0.00 Cr | -0.49 Cr | 41.7700 Cr |
| 2022-03-31 | 1.17 Cr | 76.19 Cr | 38.87 Cr | 37.3200 Cr | 12.60 Cr | 8.27 Cr | 18.11 Cr | 16.10 Cr | 0.14 Cr | 0.00 Cr | 0.00 Cr | 38.1398 Cr |
| 2021-03-31 | 2.83 Cr | 75.62 Cr | 43.16 Cr | 32.4578 Cr | 15.05 Cr | 12.22 Cr | 14.55 Cr | 15.31 Cr | 1.81 Cr | 0.10 Cr | 0.11 Cr | 37.9542 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.8921 Cr | -3.4599 Cr | -0.5200 Cr | 1.7074 Cr | 0.9122 Cr | 1.0949 Cr | -3.1847 Cr | 10.0932 Cr | -0.5200 Cr | 0.0000 Cr | -10.3892 Cr |
| 2024-03-31 | 2.4379 Cr | -2.6766 Cr | -0.4900 Cr | 0.2044 Cr | -0.7287 Cr | 0.1827 Cr | -2.4783 Cr | 8.2909 Cr | -1.3415 Cr | 0.0000 Cr | 3.3615 Cr |
| 2023-03-31 | 8.1672 Cr | -6.6035 Cr | -1.8173 Cr | 1.5749 Cr | -0.2536 Cr | 0.9114 Cr | -6.5923 Cr | 7.2415 Cr | -1.2182 Cr | 0.0000 Cr | -1.5910 Cr |
| 2022-03-31 | 5.8620 Cr | -1.7564 Cr | -5.7710 Cr | -1.1500 Cr | -1.6654 Cr | 6.2500 Cr | -2.8600 Cr | 4.8900 Cr | -3.0988 Cr | 0.0000 Cr | -3.5600 Cr |
| 2021-03-31 | -11.3100 Cr | -16.9600 Cr | 18.2800 Cr | 0.4721 Cr | -9.9900 Cr | 2.8304 Cr | -2.1360 Cr | 2.5917 Cr | 4.9500 Cr | 0.0000 Cr | 3.7087 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 58.68 Cr | 47.03 Cr | 11.66 Cr | 0.1986 | 3.54 Cr | 2.87 Cr | 0.35 | 4.33 Cr | 0.0489 |
| 2025-09-30 | 52.64 Cr | 40.44 Cr | 12.19 Cr | 0.2316 | 1.98 Cr | 2.57 Cr | 0.31 | 4.44 Cr | 0.0488 |
| 2025-06-30 | 38.25 Cr | 27.34 Cr | 10.91 Cr | 0.2853 | 2.06 Cr | 1.82 Cr | 0.22 | 3.48 Cr | 0.0475 |
| 2025-03-31 | 41.30 Cr | 27.36 Cr | 13.94 Cr | 0.3375 | 12.36 Cr | 4.34 Cr | 0.52 | 6.66 Cr | 0.1051 |
| 2024-12-31 | 39.49 Cr | 28.66 Cr | 10.83 Cr | 0.2742 | 2.35 Cr | 2.62 Cr | 0.32 | 4.54 Cr | 0.0663 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.27 Cr | 1.50 Cr | 1.76 Cr | 57.66 Cr | 41.38 Cr | 113.80 Cr | 21.27 Cr | 137.36 Cr | 70.50 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 2.55 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -62.47 Cr |
| 2025-03-31 | 1.09 Cr | 1.45 Cr | 2.55 Cr | 57.18 Cr | 26.73 Cr | 96.68 Cr | 21.58 Cr | 119.80 Cr | 57.33 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1.52 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -55.51 Cr |
| 2024-09-30 | 0.12 Cr | 1.41 Cr | 1.52 Cr | 0.20 Cr | 17.05 Cr | 77.02 Cr | 20.94 Cr | 99.04 Cr | 43.53 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 1.82 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 4.34 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 2.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 1.55 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 1.58 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2023-03-16 | March 16, 23 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,812.80 | ₹4,349,514,433,616.00 | ₹3,298,187.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,372.00 | ₹1,691,565,791,760.00 | ₹298,134.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,427.80 | ₹1,498,568,719,232.00 | ₹373,853.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,314.60 | ₹1,094,510,791,983.00 | ₹2,328,593.00 |
| Lupin Limited | LUPIN | ₹2,337.40 | ₹1,068,292,308,200.00 | ₹1,118,737.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹923.10 | ₹928,854,596,169.00 | ₹548,985.00 |
| Mankind Pharma Limited | MANKIND | ₹2,237.70 | ₹923,733,909,614.00 | ₹1,043,890.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,285.90 | ₹746,852,807,016.00 | ₹2,197,557.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,616.50 | ₹671,536,822,500.00 | ₹127,559.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,225.80 | ₹628,122,560,672.00 | ₹1,554,299.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,038.00 | ₹560,371,132,116.00 | ₹1,367,251.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,491.20 | ₹378,323,729,882.00 | ₹56,999.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,999.90 | ₹374,794,378,438.00 | ₹123,025.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,117.40 | ₹339,967,004,084.00 | ₹706,890.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,567.80 | ₹297,211,828,212.00 | ₹871,597.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,815.50 | ₹220,387,500,000.00 | ₹3,477.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,327.40 | ₹215,692,105,131.00 | ₹576,727.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹1,039.20 | ₹186,130,976,904.00 | ₹2,029,982.00 |
| Eris Lifesciences Limited | ERIS | ₹1,351.10 | ₹184,042,641,430.00 | ₹100,690.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹12,597.00 | ₹161,618,111,733.00 | ₹24,766.00 |
| Granules India Limited | GRANULES | ₹581.30 | ₹141,063,489,700.00 | ₹712,670.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹712.35 | ₹140,021,741,381.00 | ₹50,451.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹812.35 | ₹128,651,664,788.00 | ₹293,109.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,684.10 | ₹128,011,297,234.00 | ₹43,345.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹940.65 | ₹115,451,618,400.00 | ₹42,515.00 |
| Cohance Lifesciences Limited | COHANCE | ₹295.60 | ₹113,086,846,584.00 | ₹907,550.00 |
| Viyash Scientific Limited | VIYASH | ₹197.45 | ₹86,151,137,188.00 | ₹1,162,070.00 |
| Procter & Gamble Health Limited | PGHL | ₹4,892.10 | ₹81,205,836,682.00 | ₹11,986.00 |
| Strides Pharma Science Limited | STAR | ₹872.90 | ₹80,457,562,051.00 | ₹160,822.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹500.60 | ₹76,642,890,235.00 | ₹265,090.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹338.65 | ₹66,233,781,988.00 | ₹758,443.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹686.70 | ₹62,254,676,925.00 | ₹118,363.00 |
| FDC Limited | FDC | ₹378.05 | ₹61,550,352,256.00 | ₹52,686.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹124.37 | ₹40,360,749,900.00 | ₹1,617,219.00 |
| Innova Captab Limited | INNOVACAP | ₹703.35 | ₹40,249,153,812.00 | ₹21,279.00 |
| Suven Life Sciences Limited | SUVEN | ₹144.43 | ₹33,500,801,218.00 | ₹421,279.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹301.45 | ₹32,847,579,134.00 | ₹64,137.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹353.45 | ₹32,259,381,500.00 | ₹243,536.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,908.60 | ₹31,566,364,029.00 | ₹7,443.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹289.65 | ₹29,046,827,863.00 | ₹71,884.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹509.55 | ₹25,843,919,953.00 | ₹191,509.00 |
Key Executives
Gender: Not Specified
Year Born:
Gender: Not Specified
Year Born:
Gender: male
Year Born: 1955
Gender: male
Year Born: 1985
Gender: male
Year Born: 1976
Gender: male
Year Born: 1988
Gender: Not Specified
Year Born:
FAQs about Medico Remedies Limited
The CEO is Haresh Kapurlal Mehta.
The current price is ₹45.01.
The range is ₹37.18-66.05.
The market capitalization is ₹373.51 crores.
The P/E ratio is 32.20.
The company operates in the Healthcare sector.
Overview of Medico Remedies Limited (ISIN: INE630Y01024) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹373.51 crores and an average daily volume of 276,762 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.